Improving Access to Affordable Medicines in Public Hospitals (ADB-49194-001)

Countries
  • Mongolia
Where the impacts of the investment may be experienced.
Specific Location
Nation wide
Whenever identified, the area within countries where the impacts of the investment may be experienced. Exact locations of projects may not be identified fully or at all in project documents. Please review updated project documents and community-led assessments.
Financial Institutions
  • Asian Development Bank (ADB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Active
Bank Risk Rating
B
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Sep 29, 2015
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Borrower
Government of Mongolia
The holder of the loan, grant, or other investment.
Sectors
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Grant
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 1.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 1.10 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ ADB website

Updated in EWS Aug 11, 2017

Disclosed by Bank Sep 30, 2016


Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
In order to improve access to medicines by ensuring availability, affordability and physical accessibility to quality generic essential medicines, there is a need to introduce a more cost-efficient and effective system of pooled procurement of medicines for public hospitals along with establishment of in-house drug retailers in public hospitals . The pooled procurement system will increase purchasing power of public hospitals, decrease cost of medicines by increasing number of competitive suppliers and reducing manufacturer's selling price as well as drug wholesale mark-ups. The system will also improve the quality of medicines. Public hospitals will be permitted to run in-house drug retail stores for their outpatient clinic patients and serve with medicines purchased under bulk contracts and with agreed minimal mark-ups. The new system will be designed based on comprehensive analysis of the pharmaceutical sector and piloted prior to nationwide implementation. Substantial technical assistance is needed in a range of activities and technical areas, such as advocacy, human resource development, and public information education and communication campaign. IMPACT Household's health expenditure reduced, especially among the poor. Efficiency of the medicines procurement and supply system increased. Continuous and equitable access to essential medicines ensured. CONSULTING SERVICES The TA will engage 44 person months of consulting firm (22 person months of international and 22 person months of national consultants) specialized in medicines and public procurement systems, medicines supply and medicines regulatory functions. The MOHS will establish a project implementation unit (PIU) to manage day-to-day activities of the project. The PIU will comprise health specialist - project coordinator (36 person months) and finance and administrative coordinator (36 person months). The two project coordinators will be recruited by the executing agency through an individual consultant selection process. International and national consultants will be selected and engaged in accordance with ADB's Guidelines on the Use of Consultants (2013, as amended from time to time).
Investment Description
  • Asian Development Bank (ADB)
Contact Information
Ministry of Health (formerly Ministry of Health and Sports) 1st Floor, Government Building VIII Olympic Street 2, Ulaanbaatar, Mongolia ACCOUNTABILITY MECHANISM OF ADB The Accountability Mechanism is an independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an Asian Development Bank-financed project. If you submit a complaint to the Accountability Mechanism, they may investigate to assess whether the Asian Development Bank is following its own policies and procedures for preventing harm to people or the environment. You can learn more about the Accountability Mechanism and how to file a complaint at: http://www.adb.org/site/accountability-mechanism/main